Search
Prelude Therapeutics Inc
PRLDAdd to Watchlist
4.910USD
0.0000.00%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
309.10MMarket Cap
LossP/E TTM
Prelude Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-07-02The current valuation score of Prelude Therapeutics Inc is 5.99, ranking 371 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -4.93, which is -92.65% below the recent high of -0.36 and -8.55% above the recent low of -5.35.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.